Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Accumulated Expenses: 2015-2024

Historic Accumulated Expenses for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $21.1 million.

  • Wave Life Sciences' Accumulated Expenses rose 12.60% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 12.60%. This contributed to the annual value of $21.1 million for FY2024, which is 25.27% up from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' Accumulated Expenses is $21.1 million, which was up 25.27% from $16.8 million recorded in FY2023.
  • Wave Life Sciences' 5-year Accumulated Expenses high stood at $21.1 million for FY2024, and its period low was $12.0 million during FY2020.
  • In the last 3 years, Wave Life Sciences' Accumulated Expenses had a median value of $17.6 million in 2022 and averaged $18.5 million.
  • In the last 5 years, Wave Life Sciences' Accumulated Expenses dropped by 26.04% in 2020 and then rose by 25.27% in 2024.
  • Yearly analysis of 5 years shows Wave Life Sciences' Accumulated Expenses stood at $12.0 million in 2020, then increased by 24.14% to $14.9 million in 2021, then rose by 18.11% to $17.6 million in 2022, then dropped by 4.12% to $16.8 million in 2023, then rose by 25.27% to $21.1 million in 2024.